Market Research Logo

Pediatric Vaccines Market - Global Forecast to 2026

Pediatric Vaccines Market - Global Forecast to 2026

Report Description

Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as diphtheria, hepatitis A, hepatitis B, influenza, Haemophilus influenzae type b (Hib), measles, and mumps. Various government healthcare organizations such as the United Nations Children's Fund (UNICEF), American Academy of Pediatrics (AAP), and World Health Organization (WHO) are engaged in initiating various immunization awareness programmes to increase vaccination among the pediatric population.
Market Dynamics
The Centers for Disease Control and Prevention (CDC) recommends immunizing children against most of the vaccine preventable disease by the time they are two years old. These resulted in elimination of some of the infectious disease completely in various countries. For instance, Polio and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014, World Health Organisation (WHO) declared India as polio-free nation.
Increasing prevalence of chronic and infectious disease, along with growing awareness regarding childhood immunization among various developed and emerging economies lead to boost the growth of pediatric vaccines market in near future. Furthermore, increasing alliances, partnership, and collaborations among key players to introduce
efficient vaccines in the market is expected to drive growth of the market in near future.
Key features of the study:

  • This report provides in-depth analysis of pediatric vaccines and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pediatric vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, pediatric vaccine manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation:
  • Global Pediatric Vaccines Market, By Vaccine Type:
  • Monovalent
  • Multivalent
  • Global Pediatric Vaccines Market, By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • Global Pediatric Vaccines Market, By Application:
  • Infectious Disease
  • Allergy
  • Global Pediatric Vaccines Market, By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Global Pediatric Vaccines Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Europe
  • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Rest of Asia Pacific
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Latin America
  • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Vaccine Type:
  • Monovalent
  • Multivalent
  • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • By Application
  • Infectious Disease
  • Allergy
  • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Company Profiles
  • GlaxoSmithKline plc*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments
  • Strategies
  • Serum Institute of India Pvt. Ltd.
  • Eli Lilly Company
  • AstraZeneca plc
  • Pfizer, Inc.
  • Aventis Pharma Limited
  • Indian Immunologicals Limited
  • Zydus Cadila
  • Panacea Drugs Pvt. Ltd.
  • Sinovac Biotech Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Vaccine Type
Market Snippet By Vaccine Form
Market Snippet By Application
Market Snippet By End-User
Market Snippet By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Epidemiology
Key Developments
Awareness Strategies
Merger and Acquisitions
Regulatory Scenario
New Product Approvals/Launch
PEST Analysis
Porter’s Analysis
4. Global Pediatric Vaccines Market, By Vaccine Type, 2016 - 2026 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-O-Y Growth Analysis, 2017 - 2026
Segment Trends
Monovalent
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Multivalent
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
5. Global Pediatric Vaccines Market, By Vaccine Form, 2016 - 2026 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-O-Y Growth Analysis, 2017 - 2026
Segment Trends
Attenuated Live Viruses
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Inactivated Viruses
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Subunits
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Toxoids
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Recombinant
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Polysaccharides
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Conjugates
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
6. Global Pediatric Vaccines Market, By Application, 2016 - 2026 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-O-Y Growth Analysis, 2017 - 2026
Segment Trends
Infectious Disease
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-O-Y Growth Analysis, 2017 - 2026
Allergy
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
7. Global Pediatric Vaccines Market, By End-User, 2016 - 2026 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-O-Y Growth Analysis, 2017 - 2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Pediatric Clinics
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Academic & Research Organizations
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
8. Global Pediatric Vaccines Market, By Regions, 2016 - 2026 (US$ Million)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-O-Y Growth Analysis, For Regions, 2017 - 2026
North America
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
9. Competitive Landscape
Heat Map Analysis
Company Profiles
GlaxoSmithKline plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Serum Institute of India Pvt. Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Eli Lilly Company
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
AstraZeneca plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Aventis Pharma Limited
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Indian Immunologicals Limited
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Zydus Cadila
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Panacea Drugs Pvt. Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Sinovac Biotech Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Analyst Views
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 39 figures on “Pediatric Vaccines Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report